Derek Maetzold is President and Chief Executive Officer of Castle BioSciences Inc (CSTL). The company reported total compensation of $6,786,771 for fiscal year 2025.
| Salary | $751,350 |
|---|---|
| Bonus | $0 |
| Stock awards | $4,977,208 |
| Option awards | $0 |
| Non-equity incentive plan | $1,036,863 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $21,350 |
| Total | $6,786,771 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Castle BioSciences Inc filed April 8, 2026, accession 0001628280-26-024166.
| Peer-group chief executive median | $14,252,269 |
|---|---|
| Difference from that median | $-7,465,498 |
| Percentile within the disclosed peer group | 1st |
| Peers with a disclosed figure | 2 |
Medians and percentiles are computed across the peer group Castle BioSciences Inc discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Derek Maetzold this page | President and Chief Executive Officer | $6,786,771 |
| Frank Stokes | Chief Financial Officer | $2,419,837 |
| Kristen Oelschlager | Chief Operating Officer | $2,362,571 |
| Tobin Juvenal | Chief Commercial Officer | $2,362,571 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Castle BioSciences Inc compensation brief.
Derek Maetzold's compensation sits inside Castle BioSciences Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.